Trial intelligence / Profile preview

Esketamine vs Alfentanil for propofol-based general anesthesia in hysteroscopy

ChiCTR2300077283Phase 4Recruiting

Sponsor
First Affiliated Hospital, Zhejiang University School of Medicine
Start
Nov 2023
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of esketamine, alfentanil and propofol (2 arms), sponsored by First Affiliated Hospital, Zhejiang University School of Medicine. Primary endpoints: Incidence of respiratory depression and Incidence of adverse events (circulatory system). Started Nov 2023; status: recruiting.

02

Drugs

esketaminealfentanilpropofol

Beyond the preview

Go deeper on ChiCTR2300077283.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2300077283.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call